Navigation Links
Global Imaging Agents Industry
Date:5/19/2011

2; in Canada 55

VisEn Introduces ProSense® 750 FAST and Neutrophil ElastaseTM

680 FAST 55

Bayer Works on Development of MR Contrast Agents for Breast

Cancer Diagnosis 55

Lantheus Medical Imaging Introduces ABLAVAR™ MRA Imaging Agent 56

VisEn Introduces Cat B 680 FAST™ Imaging Agent 56

VisEn Medical Introduces GastroSense 750 Fluorescence Imaging

Agent 56

VisEn Medical Unveils VivoTag® 645 Red Fluorescent Dye 57

VisEn Medical Launches VivoTag® 680 XL Fluorescent Dye 57

AMAG Pharmaceuticals Unveils Superparamagnetic Iron Oxide

Nanopaticles 57

MabCure Unveils Monoclonal Antibodies 57

VisEn Medical Introduces ReninSense680TM FAST 58

VisEn Medical Introduces New VivoTag® 800 and OsteoSense®

Imaging Agents 58

VisEn Medical Introduces Annexin-Vivo 750 Imaging Agent 58

VisEn Introduces New Fluorescence Molecular Imaging Agent,

IntegriSense™ 750 59

Bayer to Launch Primovist™ and Nexavar™ in Japan 59

Sanochemia Unveils MR-Lux® 60

VisEn Medical Introduces New Fluorescence in Vivo Imaging

Agent, IntegriSense 60

Bayer to Unleash Radiology Management System 61

Bayer to Unveil Pre-Filled Contrast-Medium Cartridges for MRI 61

10. RECENT INDUSTRY ACTIVITY 62

University of Montana Receives Patents for Two New Brain

Imaging Agents 62

Eli Lilly Acquires Avid Radiopharmaceuticals 62

GE Global Research Secures Multi-Year NIH Grant to Develop

Nerve Imaging Agent and Imaging System 62

Agfa Healthcare Snaps Insight Agents 62

Nordion to Divest MDS Nordion S.A. 63

Sofie Biosciences Secures Funds for Research on Molecular PET

Imaging Agents 63

Aposense Signs Collaboration Agreement With Roche 63

University of Washington to Collaborate with Cardinal Health

for Advancement of
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23

Related medicine technology :

1. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
2. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
3. Directors Forum: PEPFAR and the Global AIDS Response
4. Alfacell Corporation to Present at UBS Global Life Sciences Conference
5. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
6. Global HIV Vaccine Enterprise Names Alan Bernstein as Inaugural Executive Director, Opens New Secretariat
7. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
8. Hillary Clinton Pledges Bold Approach to Stopping HIV/AIDS & Global Poverty
9. IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
10. Dr. Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery
11. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... Insulet Corporation (NASDAQ: PODD ), the ... ® Insulin Management System, today announced preliminary revenue ... The Company also announced that it will postpone the ... conference call from Thursday, July 30, as originally scheduled. ... , Preliminary second quarter revenue ...
(Date:7/29/2015)... 2015  UBM Canon brings MEDevice San Diego Conference ... Marina on September 1-2, 2015, with a multi-track conference ... the Business Development track will be a panel on ... Investors, featuring Renee Ryan , Vice President of ... Ahrens , Partner, Canaan Partners; and Jordan Kramer ...
(Date:7/29/2015)... 2015  According to data released today by the ... monthly Medicare Part D premium is expected to remain ... originally projected, the Pharmaceutical Care Management Association (PCMA) said. ... be a bright spot in American health care. By ... and using cutting edge, cost-saving tools like pharmacy networks ...
Breaking Medicine Technology:Insulet Reports Preliminary Second Quarter 2015 Revenue Results 2Insulet Reports Preliminary Second Quarter 2015 Revenue Results 3Insulet Reports Preliminary Second Quarter 2015 Revenue Results 4Insulet Reports Preliminary Second Quarter 2015 Revenue Results 5MEDevice San Diego Offers Tips on Securing Financial Backing from Investors 2
(Date:7/30/2015)... ... ... Quintessa Medical Spa is happy to offer patients the latest treatment for ... the elimination of excess tissue under the chin, referred to as submental fat. ... offer this innovative treatment. , Developed by Kythera Biopharmaceuticals, Kybella was approved by the ...
(Date:7/30/2015)... ... 30, 2015 , ... The New Jersey Innovation Institute (NJII), ... of Health, has received a $2.9 million grant from the Office of the ... Health and Human Services (HHS). NJII will help the Department of Health ensure ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... Bird B ... a new bird hazing system to repel pest birds from the AC ... diseases—including histoplasmosis, encephalitis, salmonella, meningitis, and toxoplasmosis, even the West Nile virus. When these ...
(Date:7/30/2015)... ... ... After conducting a nationwide executive search led by healthcare leadership solutions firm ... N.Y., has hired Gerard (Jerry) Walsh as Chief Executive Officer. Walsh assumed his new ... Walsh is an expert in organizational change, physician development, implementation of quality and patient ...
(Date:7/30/2015)... Springfield, Mo (PRWEB) , ... July 30, 2015 , ... ... home health and hospice care, announced today that it is hosting a free webinar ... St. Pierre, RN, BSN, MGA, HEALTHCAREfirst Consultant and former Vice President of Regulatory Affairs ...
Breaking Medicine News(10 mins):Health News:Quintessa MedSpa Offers Nonsurgical Double-chin Elimination 2Health News:New Jersey Innovation Institute Awarded $2.9 Million Federal Grant to Advance Health Information Technology Services to Support Health Information Exchange 2Health News:Bird B Gone’s New Bird Hazing System Keeps Disease-Carrying Bird Droppings Out of Hospitals 2Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 2Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 3Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 4Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 5Health News:HEALTHCAREfirst Announces Home Health Industry Regulatory Review Webinar 2
... CellCyte Genetics Corporation (CellCyte) (OTC Bulletin Board: ... published by the Seattle Times reporting ... incorrectly reported that CellCyte ,closes.,In CellCyte,s August 14, ... its bioreactor business segment and generally described its ...
... Dec. 29 Watson Pharmaceuticals,Inc. (NYSE: ... branded pharmaceuticals,today announced that its subsidiary, Watson Laboratories, ... Food and Drug Administration on its,Abbreviated New Drug ... USP, 0.15 mg / 0.02 mg. Desogestrel/ethinyl,estradiol ...
... Priority ReviewEAST BRUNSWICK, N.J., Dec. 29 Savient ... announced that the U.S. Food and Drug Administration ... License Application (BLA) for pegloticase, a novel biological ... also granted the Company,s BLA with a priority ...
... Cross and Blue Shield of Oklahoma announced today the ... their next policy year. This change will not in ... always been available to children with autism. Blue Cross ... interests in the benefits and coverage of certain autism-related ...
... Dec. 29 Eastern Life & Health Insurance Company (ELH), ... EIHI ), announced today that it will add vision to ... include a vision insurance plan and a vision discount program, ... "Adding vision to ELH,s product portfolio enables employers to offer ...
... 29 Life for Relief and Development (LIFE), a ... the civilian victims of the recent conflict in Gaza. ... non-governmental organizations operating in the area, LIFE has obtained ... relief items to Gaza via a specially designated humanitarian ...
Cached Medicine News:Health News:CellCyte Genetics Corporation: Seattle Times Erroneously Reports That CellCyte 'Closes' 2Health News:CellCyte Genetics Corporation: Seattle Times Erroneously Reports That CellCyte 'Closes' 3Health News:CellCyte Genetics Corporation: Seattle Times Erroneously Reports That CellCyte 'Closes' 4Health News:CellCyte Genetics Corporation: Seattle Times Erroneously Reports That CellCyte 'Closes' 5Health News:Watson Pharmaceuticals Receives FDA Final Approval for Generic Mircette(R) 2Health News:Pegloticase BLA Filing Accepted for Priority Review by FDA 2Health News:Pegloticase BLA Filing Accepted for Priority Review by FDA 3Health News:Pegloticase BLA Filing Accepted for Priority Review by FDA 4Health News:Blue Cross and Blue Shield of Oklahoma Announces Autism Benefits 2Health News:Eastern Life & Health Introduces New Vision Product 2Health News:Eastern Life & Health Introduces New Vision Product 3
... of any biological activity but appears to ... of insulin. Although insulin and C-Peptide are ... fasting levels of C-Peptide are 5-10 fold ... the longer half-life of C-Peptide. The glucagon ...
... The Array Multifocal IOL was designed ... with independence from glasses in most situations. ... IOL is similar to that of a ... usually much better and about 19 in ...
Inquire...
... IgG Enzymelinked Immunosorbent Assays(ELISA) is intended for ... antibody to Measles Rubeola) virus in human ... for the determination of immune status. Paired ... demonstrate seroconversion or a significant rise in ...
Medicine Products: